Physician profile
James B Waters
NPI 1821038878
$803.87
in general payments reported to CMS, 2019-2025
19 companies · $157 in 2025
The $157 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $94.47 · 2021: $53.11 · 2022: $123 · 2023: $38.99 · 2024: $134 · 2025: $157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $119.03 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $67.94 | 2021-2022 | |
| Pfizer INC. | $61.67 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $61.05 | 2019 | |
| Amgen INC. | $55.45 | 2019-2024 | Repatha |
| Ge Healthcare | $48.66 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $48.43 | 2019-2024 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $47.05 | 2021-2024 | Wainua |
| Abbott Laboratories | $42.43 | 2020-2024 | Accent |
| Merck Sharp & Dohme LLC | $40.07 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.73 | 2021-2023 | Lifevest |
| Penumbra, INC. | $31.75 | 2025 | Indigo System |
| Lantheus Medical Imaging, INC. | $23.84 | 2019 | |
| Bridgebio Pharma, INC. | $22.80 | 2025 | Attruby |
| Opsens INC. | $22.60 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $19.96 | 2020 | |
| Boston Scientific Corporation | $19.02 | 2020 | |
| Abiomed | $17.58 | 2019 | |
| Astellas Pharma US INC | $14.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Waters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.